Analyse Adaltis S.r.l de la part de marché pour novembre 2025

adaltis s.r.l. is an international, ivd company headquartered in rome, italy. adaltis develops, manufactures and markets in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases and measure human hormone responses. recently adaltis developed systems and reagents for the molecular diagnostics / rt pcr testing (extraction and purification platform). personal lab - fully automated 2 plate microelisa analyser, including ifa preparation features nexgen - fully automated 7 plate microelisa analyser, including ifa preparation features. mdxlab - fully integrated nucleic acid extraction & detection universal & compact platform for clinical diagnostics - nucleic acid extraction, pcr set-up, pcr amplification & detection extralab - advanced robotic systems for extraction & purification of nucleic acids, genomics & proteomics. genetics azf microdeletions kit - male fertility and y chromosome microdeletions